We are very proud to be the first Hong Kong-based carrier to have achieved CEIV certification. As an industry, air freight previously lacked consistency in moving time and temperature-sensitive life-science products. Consistency and quality are vital for these types of shipments. Customers need assurance that their valuable and life-saving shipments are transported safely, but our industry’s inconsistencies were opening opportunities to competitors from rail and seafreight.
As it stands, different airlines might have their own individual approaches and processes, while some pharma companies were already carrying out their own validation of carriers. It was therefore good news for us as an industry and for our customers that IATA developed CEIV. It is specific, industry-led guidance and certification to the very highest standard.
CEIV brings very stringent operational safety plans and processes for us to follow and practices that will govern the overall standards of pharmaceutical transportation for the airfreight industry. This will be manifested through stringent pre-validation assessments on an airline’s pharma capabilities and validation methodology that is applied to all carriers to ensure standardised measurement.
We view CEIV as the leading programme and so it is important that we achieved the certification which allows us to offer the highest possible quality for our PharmaLift product. We have conducted a review of our processes and implemented training programmes for our people so that we deliver the best service to our customers.